Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Clinical trial NCT01478321 · TERMINATED
Trial details
- NCT number
- NCT01478321
- Sponsor
- Northwestern University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-14
- Primary completion
- 2018-09-12
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.